STRIDES PHARMA SCIENCE LIMITED — AGM Information 2024

Sep 25, 2024

September 25, 2024

The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001.

Scrip Code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051.

Scrip Code: STAR

Dear Madam/ Sir,

Sub : Proceedings of the 33[rd] Annual General Meeting (AGM) of the Company

We wish to inform you that the 33[rd] AGM of the Company was held on Wednesday, September 25, 2024 at 11:00 hrs IST, through Video Conference.

Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed summary of proceedings of AGM.

This is for your information and records.

Thanks & Regards, For Strides Pharma Science Limited

==> picture [93 x 91] intentionally omitted <==

MANJU Digitally signed by MANJULA R LA R Date: 2024.09.25 16:08:22 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

Encl. as above

==> picture [499 x 51] intentionally omitted <==

SUMMARY OF PROCEEDINGS OF 33[RD ] ANNUAL GENERAL MEETING OF THE COMPANY HELD ON WEDNESDAY, SEPTEMBER 25, 2024, FROM 11:00 HRS TO 12:25 HRS THROUGH VIDEO CONFERENCE.

Ms. Manjula Ramamurthy, Company Secretary of the Company, welcomed the Shareholders to the 33[rd] Annual General Meeting (‘AGM’) of the Company, which was held through video conference and in compliance with the applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder, Secretarial Standard-2, Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and various applicable Circulars issued by MCA and SEBI in this regard.

Thereafter, Manjula introduced Board Members and other Invitees present at the meeting to the Shareholders and the following was noted:

Present:

Name	Designation
Mr. Arun Kumar	Founder and Executive Chairperson
Mr. Badree Komandur	Managing Director and Group CEO
Mr. Aditya Arun Kumar	Executive Director – Business Development
Dr. Kausalya Santhanam	Independent Director and Chairperson of CSR Committee and Stakeholders’ Relationship Committee
Mr. Homi Khusrokhan	Independent Director and Chairperson of Audit Committee and Risk Management Committee
Mr. Ameet Hariani	Independent Director and Chairperson of Nomination and Remuneration Committee
Mr. Subir Chakraborty	Independent Director
Mr. Vikesh Kumar	Group CFO

==> picture [500 x 51] intentionally omitted <==

Other Invitees present at the meeting were noted as under:

Other Invitees present at the meeting	were noted as under:
Mr. Sampad Guha & Mr. Deepak Baid	From B S R & Co. LLP, Chartered Accountants, Statutory Auditors of the Company
Mr. Anup Thomas	From Grant Thornton Bharat LLP, Internal Auditors of the Company
Mr. Gigi Joseph K J	Partner of M/s. Joseph and Chacko LLP, Company Secretaries, Bengaluru Scrutinizer for E-voting Process

Thereafter, Kfin Technologies Limited (Kfin/ RTA) confirmed presence of requisite quorum for the meeting. Mr. Arun Kumar chaired and called the meeting to order.

Mr. Arun Kumar greeted the Shareholders and requested Mr. Badree Komandur to brief the Shareholders on Company’s performance for the financial year ended March 31, 2024, amongst other matters.

Thereafter, Mr. Badree Komandur commenced his update to the Shareholders.

Post Badree’s presentation, Speaker Shareholders who had registered with the Company for speaking at the AGM were provided an opportunity to express their views or ask their queries about the Company and Agenda Items of the AGM.

Queries were adequately responded by Mr. Arun Kumar and Mr. Badree Komandur.

As AGM Notice and Annual Report for FY24 were already circulated to all Shareholders, AGM Notice convening the meeting, Board’s Report and Auditor’s Report were taken as read.

Shareholders were informed that:

• 1) Auditor’s Report for the Consolidated and Standalone statements of the Company for the financial year ended March 31, 2024, does not contain any qualification, observations or adverse comments.

• 2) Requisite Statutory Registers and other documents referred to in the AGM Notice were available for inspection electronically by the Shareholders.

• 3) Certificate from Secretarial Auditor of the Company, certifying that the existing ESOP Scheme of the Company have been implemented in accordance with SEBI Regulations and in line with Shareholders’ approval, was also available for e-inspection.

==> picture [500 x 51] intentionally omitted <==

Thereafter, following items of business as mentioned in the AGM Notice were transacted at the meeting:

#	Resolutions Description	Type of
		Resolution
Ordinary Business
1	Adoption of Audited Financial Statements for the Financial Year ended March 31, 2024	Ordinary
2	Declaration of Final Dividend for the Financial Year ended March 31, 2024	Ordinary
3	Re-appointment of Mr. Badree Komandur, retiring Director	Ordinary
Special Business
4	Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2024	Ordinary
5	Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2025	Ordinary

Shareholders were informed that insta voting facility is available for those shareholders who have not voted during the remote e-voting period. Accordingly, Shareholders were given the facility to vote on the Kfin platform for the next 30 minutes.

Shareholders were informed that e-voting results along with Scrutinizer’s Report would be declared within two working days of conclusion of the AGM.

Thereafter, meeting ended with a vote of thanks by the Chairperson.

For Strides Pharma Science Limited,

MANJU Digitally signed by MANJULA R LA R Date: 2024.09.25 16:09:02 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

==> picture [94 x 92] intentionally omitted <==

==> picture [500 x 51] intentionally omitted <==